About Delee
Delee is a company based in Laredo (United States) founded in 2017. Delee has raised $1.3 million across 2 funding rounds from investors including Y Combinator. The company has 3 employees as of December 31, 2022. Delee offers products and services including CytoCatch Isolation Platform and CytoCatch Imaging System. Delee operates in a competitive market with competitors including Scholar Rock, Lightpoint Medical, Chromition, Nodexus and Preora Healthcare, among others.
- Headquarter Laredo, United States
- Employees 3 as on 31 Dec, 2022
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Delee Corp
-
Annual Revenue
$55.61 K (USD)0as on Mar 21, 2021
-
Net Profit
-$37.21 K (USD)92as on Dec 31, 2022
-
EBITDA
Not available
-
Total Equity Funding
$1.3 M (USD)
in 2 rounds
-
Latest Funding Round
$1.18 M (USD), Seed
Dec 09, 2019
- Investors
-
Employee Count
3
as on Dec 31, 2022
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Delee
Delee offers a comprehensive portfolio of products and services, including CytoCatch Isolation Platform and CytoCatch Imaging System.
Automated system for high-efficiency isolation of circulating tumor cells.
AI-driven tool for classifying and enumerating tumor cells in samples.
People of Delee
Unlock access to complete
Unlock access to complete
Funding Insights of Delee
Delee has successfully raised a total of $1.3M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.18 million completed in December 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Delee
Delee has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Y Combinator.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage startups are accelerated via funding and educational programs.
|
Locked | Locked | Locked |
Investor details for Delee
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Delee
Investment portfolio details for Delee
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Delee
Detailed financials for Delee
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Delee Comparisons
Peer comparison for Delee
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Delee
Delee operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Scholar Rock, Lightpoint Medical, Chromition, Nodexus and Preora Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Antibody-based drugs for primary myopathies are developed and targeted.
|
|
| Locked | Locked | Locked |
Intraoperative imaging devices for real-time cancer detection are developed.
|
|
| Locked | Locked | Locked |
Nanoparticle-based solutions for displays and lighting are provided.
|
|
| Locked | Locked | Locked |
Microfluidic systems are developed for detecting metastatic cancer.
|
|
| Locked | Locked | Locked |
Pre-screening cancer tests are offered via nanoscale cytology platform.
|
Detailed competitors of Delee
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Delee
Complete news archive for Delee
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delee
Delee was founded in 2017.
Delee is headquartered in Laredo, United States. It is registered at Laredo, Texas, United States.
Delee is a funded company, having raised a total of $1.3M across 2 funding rounds to date.
As of Dec 31, 2022, the latest employee count at Delee is 3.
Annual revenue of Delee is $55.61K as on Mar 21, 2021.
Delee was founded in 2017 in Laredo, United States, and operates in the medical device sector focused on oncology. The CytoCatch device, comprising an isolation platform and imaging system, is utilized to separate and examine circulating tumor cells from blood samples. This technology supports ongoing assessment of cancer progression and therapy outcomes in clinical settings.
Delee's top competitors include Scholar Rock, Lightpoint Medical and Nodexus.
Delee offers CytoCatch Isolation Platform and CytoCatch Imaging System.
Delee has 1 investor. Key investors include Y Combinator.